How to Stop Tirzepatide: What Happens and What to Expect

Do you need to taper tirzepatide before stopping?

No tapering schedule is required under the licensed use of tirzepatide. Unlike some medicines where abrupt discontinuation carries a physical risk, stopping tirzepatide after your last weekly injection is not associated with a withdrawal syndrome. The medicine's half-life is around five days, so levels decline gradually in the bloodstream on their own.

That said, if you are currently at a higher maintenance dose, some prescribers prefer a brief step-down, not for safety reasons, but to make the transition easier on your appetite and digestion. This is a conversation worth having rather than an assumption either way. The clinical question of when to stop tirzepatide is slightly different from the how, and both deserve attention.

What you should not do is simply run out of pens and stop without telling anyone. Your prescriber needs to know, both because they may want to support next steps and because stopping changes your clinical picture for any future prescription or referral.

What tends to happen to weight after you stop?

This is the question our prescribers hear most often, and the honest answer is that weight regain is common. If you want a fuller picture of how tirzepatide works and what it is designed to do, that context helps explain why hunger and appetite return the way they do once treatment stops. Once those effects wear off, hunger returns to wherever it was before treatment, sometimes more acutely than expected in the first few weeks.

Data from the SURMOUNT programme, which studied tirzepatide across thousands of adults with obesity, showed that participants who stopped active treatment regained a meaningful proportion of lost weight over the following year. The NHS tirzepatide information page notes that treatment is intended to be used alongside a reduced-calorie diet and increased activity, and that lifestyle changes need to be maintained after stopping for results to hold.

This does not mean stopping is the wrong choice, for some people it is exactly the right one. It does mean going in clear-eyed about what support you will need. A review of your weight management approach before you stop is worth arranging rather than doing it retrospectively.

What side effects resolve when tirzepatide is stopped?

Most of the gastrointestinal effects tied to tirzepatide (nausea, loose stools, reduced appetite, reflux, burping) are dose-dependent and linked to how fast the medicine slows stomach emptying. They fade as blood levels fall after the final injection, typically within one to two weeks for most people.

If you have been experiencing persistent side effects and stopping is part of that decision, it is still worth flagging them formally. The MHRA's Yellow Card scheme exists so that patients can report suspected side effects directly, and those reports genuinely shape how the medicine is monitored over time.

One practical note: the effects on appetite that felt unwelcome during treatment (eating less, feeling full quickly) are, somewhat paradoxically, also the effects that were doing the most work. Their absence is often what prompts the weight regain described above. Being prepared for that shift rather than surprised by it makes a real difference.

How should you handle stopping if you are mid-treatment?

If you are currently on a titrated dose and thinking about stopping, start with your prescriber. At nume, every repeat order is reviewed by a named clinician before dispatch, that same clinical relationship is the right place to raise a decision to stop, not just to process repeat orders.

There are a few situations where stopping is worth discussing more urgently: a planned surgical procedure (your anaesthetist and surgical team need to know you have been on tirzepatide, and most guidance recommends pausing before certain procedures), a positive pregnancy test, or a new diagnosis that changes your picture. The practical guide to stopping Mounjaro covers the branded-pen side of this in more detail, including what to do with any unused pens.

If you are considering stopping because of cost, it is worth knowing that treatment pricing and what is included in a private prescription varies considerably between providers. The Mounjaro cost page sets out the honest market context. And if you are stopping to switch to compounded peptide instead, our guide on how to make tirzepatide and the separate page covering how to mix tirzepatide correctly are useful starting points before you make that change. If you are stopping to switch to a different approach, our prescribers can help you think through what that looks like, you can speak to our prescribers to start that conversation.